Stocks › JAZZ

Jazz Pharmaceuticals plc

JAZZ·Nasdaq·USD
$230.26
-6.19 (-2.62%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
JAZZ
Jazz Pharmaceuticals plc · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
JAZZS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of JAZZ by members of U.S. Congress · 16 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Daniel S. GoldmanDaniel S. GoldmanHouse · D · NY JAZZJazz Pharmaceuticals plc · Stock Sale
$15,001 - $50,000
Aug 13, 2023 Jul 12, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA JAZZJazz Pharmaceuticals plc · Common Stock Purchase
$1,001 - $15,000
Jun 12, 2023 May 19, 2023 Filing ↗
Daniel S. GoldmanDaniel S. GoldmanHouse · D · NY JAZZJazz Pharmaceuticals plc · Stock Purchase
$15,001 - $50,000
Apr 17, 2023 Mar 6, 2023 Filing ↗
Ro KhannaRo KhannaHouse · D · CA JAZZJazz Pharmaceuticals plc · Stock Purchase
$1,001 - $15,000
Apr 7, 2023 Mar 14, 2023 Filing ↗
Daniel S. GoldmanDaniel S. GoldmanHouse · D · NY JAZZJazz Pharmaceuticals plc · Stock Sale
$1,001 - $15,000
Feb 24, 2023 Jan 31, 2023 Filing ↗
Thomas R. SuozziThomas R. SuozziHouse · D · NY JAZZJazz Pharmaceuticals plc · Common Stock Sale
$1,001 - $15,000
Oct 14, 2022 Sep 26, 2022 Filing ↗
Ro KhannaRo KhannaHouse · D · CA JAZZJazz Pharmaceuticals plc · Common Stock Sale
$1,001 - $15,000
Jan 7, 2022 Dec 14, 2021 Filing ↗
Thomas R. SuozziThomas R. SuozziHouse · D · NY JAZZJazz Pharmaceuticals plc · Stock Purchase
$1,001 - $15,000
Nov 5, 2021 Oct 19, 2021 Filing ↗
Bill FloresBill FloresHouse · R · TX JAZZJazz Pharmaceuticals plc · Stock Purchase
$15,001 - $50,000
Aug 12, 2019 Jul 15, 2019 Filing ↗
Carlos CurbeloCarlos CurbeloHouse · R · FL JAZZJazz Pharmaceuticals plc · Stock Purchase
$1,001 - $15,000
Sep 25, 2018 Aug 28, 2018 Filing ↗
Francis RooneyFrancis RooneyHouse · R · FL JAZZJazz Pharmaceuticals plc · Stock Purchase
$1,001 - $15,000
Feb 14, 2018 Feb 1, 2018 Filing ↗
Thomas MacArthurThomas MacArthurHouse · R · NJ JAZZJazz Pharmaceuticals plc · Stock Sale
$1,001 - $15,000
Jun 7, 2015 May 27, 2015 Filing ↗
Tom PriceTom PriceHouse · R · GA JAZZJazz Pharmaceuticals plc · Stock Purchase
$1,001 - $15,000
Feb 10, 2015 Jan 9, 2015 Filing ↗
Tom PriceTom PriceHouse · R · GA JAZZJazz Pharmaceuticals plc · Stock Sale
$1,001 - $15,000
Nov 14, 2014 Oct 21, 2014 Filing ↗
Mike KellyMike KellyHouse · R · PA JAZZJazz Pharmaceuticals plc · Stock Sale
$1,001 - $15,000
Jun 23, 2014 May 13, 2014 Filing ↗
Mike KellyMike KellyHouse · R · PA JAZZJazz Pharmaceuticals plc · Stock Sale
$1,001 - $15,000
Mar 12, 2014 Feb 20, 2014 Filing ↗

Whale Activity

Position changes in JAZZ reported for 2026-09-30 by 740 institutional filers
Increased: 259New: 99Held: 84Decreased: 198Closed: 66No prior filing: 34
  • Increased259
  • New99
  • Held84
  • Decreased198
  • Closed66
  • No prior filing34
FilerSharesValueChange
BlackRock, Inc.6.5M$1.49Bincreased
FMR LLC5.5M$1.28Bincreased
VANGUARD PORTFOLIO MANAGEMENT LLC3.1M$711.2Mincreased
VANGUARD CAPITAL MANAGEMENT LLC2.8M$649.5Mincreased
Capital World Investors2.4M$554.1Mdecreased
LSV ASSET MANAGEMENT2.1M$494.5M—
STATE STREET CORP2.1M$478.8Mincreased
FRANKLIN TEMPLETON INC1.9M$456.2Mdecreased
GEODE CAPITAL MANAGEMENT, LLC1.5M$354.9Mincreased
DIMENSIONAL FUND ADVISORS LP1.5M$336.5Mdecreased
FULLER & THALER ASSET MANAGEMENT, INC.1.4M$323.8Mdecreased
AQR CAPITAL MANAGEMENT LLC1.2M$271.0Mdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by JAZZ insiders, by quarter · Form 4
-200.0K-100.0K0100.0K200.0K2025 Q1: -29.5K2025 Q12025 Q2: 97.6K2025 Q22025 Q3: -8,0002025 Q32025 Q4: -129.3K2025 Q42026 Q1: -74.0K2026 Q12026 Q2: -33.2K2026 Q22026 Q3: -98.1K2026 Q32026 Q4: -85.2K2026 Q4

Recent Insider Transactions

2,061 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
COZADD BRUCE CDirector · Director Sale −5,923 $237.39 $1.4M Nov 6, 2026 Form 4 ↗
COZADD BRUCE CDirector · Director Sale −27.7K $234.91 $6.5M Nov 6, 2026 Form 4 ↗
COZADD BRUCE CDirector · Director Sale −24.5K $236.84 $5.8M Nov 6, 2026 Form 4 ↗
COZADD BRUCE CDirector · Director Sale −10.7K $235.82 $2.5M Nov 6, 2026 Form 4 ↗
Carr PatriciaSVP, Chief Accounting Officer Sale −163 $231.27 $38K Nov 4, 2026 Form 4 ↗
Carr PatriciaSVP, Chief Accounting Officer Sale −1,250 $231.37 $289K Nov 4, 2026 Form 4 ↗
GALA RENEE DPresident & CEO · Director Sale −1,000 $225.37 $225K Nov 3, 2026 Form 4 ↗
COZADD BRUCE CDirector · Director Sale −6,000 $215.84 $1.3M Nov 2, 2026 Form 4 ↗
GALA RENEE DPresident & CEO · Director Sale −2,000 $236.40 $473K Oct 6, 2026 Form 4 ↗
COZADD BRUCE CDirector · Director Sale −6,000 $230.33 $1.4M Oct 1, 2026 Form 4 ↗
Patil Neena MEVP & Chief Legal Officer Sale −1,200 $240.94 $289K Sep 10, 2026 Form 4 ↗
Henderson Mary ElizabethSVP, Technical Operations Tax withholding −15 $241.20 $4K Sep 8, 2026 Form 4 ↗
Henderson Mary ElizabethSVP, Technical Operations Tax withholding −1,412 $243.03 $343K Sep 8, 2026 Form 4 ↗
GALA RENEE DPresident & CEO Sale −2,000 $243.03 $486K Sep 8, 2026 Form 4 ↗
GALA RENEE DPresident & CEO Tax withholding −1,967 $246.81 $485K Sep 8, 2026 Form 4 ↗
COZADD BRUCE CDirector Sale −6,000 $250.13 $1.5M Sep 1, 2026 Form 4 ↗
Kennedy PatrickDirector Tax withholding −1,840 $241.39 $444K Aug 31, 2026 Form 4 ↗
Kennedy PatrickDirector Tax withholding −15 $244.06 $4K Aug 31, 2026 Form 4 ↗
Henderson Mary ElizabethSVP, Technical Operations Tax withholding −16 $244.64 $4K Aug 31, 2026 Form 4 ↗
Henderson Mary ElizabethSVP, Technical Operations Tax withholding −2,076 $241.39 $501K Aug 31, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding JAZZ · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.9M$456.0M0.02%Jun 30, 2026
FULLERTHALER BEHAVIORAL SMALL CAP EQUITY
Capitol Series Trust
1.6M$376.3M2.97%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
1.4M$329.3M0.17%Jun 30, 2026
VANGUARD SMALL-CAP VALUE INDEX FUND
VANGUARD INDEX FUNDS
865.9K$208.7M0.31%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
719.2K$173.3M0.18%Jun 30, 2026
VictoryShares Free Cash Flow ETF
Victory Portfolios II
469.9K$113.2M1.46%Jun 30, 2026
Avantis U.S. Large Cap Value ETF
American Century ETF Trust
221.3K$55.5M0.26%Aug 31, 2026
Dimensional U.S. Small Cap ETF
Dimensional ETF Trust
168.6K$42.6M0.28%Jul 31, 2026
VANGUARD HEALTH CARE INDEX FUND
VANGUARD WORLD FUND
169.1K$42.4M0.19%Aug 31, 2026
VANGUARD WINDSOR FUND
VANGUARD WINDSOR FUNDS
201.6K$40.9M0.17%Apr 30, 2026

Mutual funds and ETFs whose N-PORT filings list JAZZ's shares (CUSIP G50871105), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 5.6M shares8.6%
    Nov 5, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 5.6M shares8.6%
    Nov 5, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G · passive (13G) · 4.7M shares7.4%
    Aug 6, 2026 · ↗
  • FMR LLCSCHEDULE 13G · passive (13G) · 4.7M shares7.4%
    Aug 6, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming jazz pharmaceuticals as client
$0$1.3M$2.5M$3.8M$5.0M2023 Q1: $1.6M2023 Q2: $940K2023 Q3: $940K2023 Q4: $1.6M20232024 Q1: $1.2M2024 Q2: $710K2024 Q3: $1.1M2024 Q4: $1.3M20242025 Q1: $600K2025 Q2: $590K2025 Q3: $630K2025 Q4: $740K20252026 Q1: $820K2026 Q2: $760K2026 Q3: $820K2026
  • MARSHALL & POPP, LLCJAZZ PHARMACEUTICALS, INC. AND ITS SUBSIDIARIES, INCLUDING GREENWICH BIOSCIENCES · 2026 Q3 · HCR, TRD$40K
    Filing ↗
  • AVENUE SOLUTIONSJAZZ PHARMACEUTICALS, INC. · 2026 Q3 · HCR, MMM$50K
    Filing ↗
  • JAZZ PHARMACEUTICALS, INC.JAZZ PHARMACEUTICALS, INC. · 2026 Q3 · PHA$550K
    Filing ↗
  • TARPLIN, DOWNS & YOUNG, LLCJAZZ PHARMACEUTICALS INC. · 2026 Q3 · HCR$80K
    Filing ↗
  • THE NICKLES GROUP, LLCJAZZ PHARMACEUTICALS, INC. · 2026 Q3 · MMM, TRD$50K
    Filing ↗

Government Contracts

Federal awards to jazz pharmaceuticals · USAspending
$517KAwarded · 3 contracts on record
  • Department of Veterans AffairsXYWAV$179K
    Mar 9, 2025 · ↗
  • Department of Veterans AffairsXYREM$106K
    Oct 1, 2026 · ↗
  • Department of Veterans AffairsPHARM - XYWAV$231K
    Oct 1, 2025 · ↗

U.S. Patents

Recent USPTO applications naming Jazz Pharmaceuticals plc

No USPTO patent applications found for Jazz Pharmaceuticals plc.

Annual Financials

From JAZZ's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$4.27B$4.07B$3.83B$3.66B$3.09B
Operating income-$430.2M$716.6M$578.6M-$65.5M$170.3M
Net income-$356.1M$560.1M$414.8M-$224.1M-$329.7M
Diluted EPS-$5.84$8.65$6.10-$3.58-$5.52
Operating cash flow$1.36B$1.40B$1.09B$1.27B$778.5M
Cash and equivalents$1.39B$2.41B$1.51B$881.5M$591.4M
Total assets$11.66B$12.01B$11.39B$10.84B$12.30B
Shareholders' equity$4.32B$4.09B$3.74B$3.09B$3.97B

As Jazz Pharmaceuticals plc tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 24, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in JAZZ's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsNov 2, 2026
    EDGAR ↗
  • 8-K · Items 2.02Results of operationsOct 26, 2026
    EDGAR ↗
  • 8-K · Items 5.02Officer / director changeOct 9, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationSep 23, 2026
    EDGAR ↗
  • 8-K · Items 7.01Reg FD disclosureSep 15, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 2.03, 3.02, 8.01, 9.01Material agreement · Direct financial obligation · Unregistered sale of equityAug 31, 2026
    EDGAR ↗
  • 8-K · Items 8.01Other eventsAug 25, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 9.01Material agreementAug 10, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureAug 10, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 3, 2026
    EDGAR ↗

About Jazz Pharmaceuticals plc

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersDUBLIN
IncorporatedL2
Former namesJAZZ PHARMACEUTICALS INC